-
Posted on
-
Cresset Announces Appointment of Rob Scoffin as New CEO
Posted onCresset is delighted to announce the appointment of Dr Robert Scoffin as Chief Executive Officer of Cresset Group. Rob joins ...
-
New Directions in Statins Research
Posted onAtorvastatin was the world’s best selling drug in 2006 with global revenues of over $13B. Key patents in the area ...
-
Cresset and Syrris Begin Strategic Partnership
Posted onSyrris has partnered with Cresset to launch MedStere to increase lead optimisation efficiency.
-
Cresset Introduces FieldStere V2.0
Posted onCresset today announced the release of a new version of its FieldStere bioisostere generator. FieldStere delivers shorter lead optimization cycles ...
-
Cresset Establishes New Versaphor Division
Posted onVersaphor offers molecular Field enabled tools to medicinal chemistry, patent, safety and in-licensing teams
-
Rational Drug Design Against GPCRs: Application to CCK2 Antagonists
Posted on -
FieldScreen 2.5.0 released
Posted on -
New Services Launched
Posted onNew Cost Efficient Lead Finding and Optimization Services Launched
-
Release of FieldStere 1.1.0
Posted onCresset announce the release of FieldStere 1.1.0 which incldues major advances in the accuracy and analysis of results
-
FieldAlign v2.1 and FieldTemplater v2.2 Released
Posted onCresset launch new versions of FieldAlign and FieldTemplater that include major enhancements in productivity and accuracy.
-
Cresset and CambridgeSoft Alliance
Posted onCresset BioMolecular Discovery Expands Sales Pipeline Potential 10 Fold through CambridgeSoft Alliance. FieldAlign and FieldTemplater Products Reach a Global Audience ...